Elan Pharmaceuticals, Inc. v. Mayo Foundation, 00-1467.
| Court | United States Courts of Appeals. United States Court of Appeals for the Federal Circuit |
| Citation | 314 F.3d 1299 |
| Docket Number | No. 00-1467.,00-1467. |
| Parties | ELAN PHARMACEUTICALS, INC. and Athena Neurosciences, Inc., Plaintiffs-Appellants, v. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Defendant-Appellee. |
| Decision Date | 18 December 2002 |
v.
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Defendant-Appellee.
Appealed from United States District Court for the Northern District of California, Judge William H. Alsup.
ON COMBINED PETITION FOR PANEL REHEARING AND REHEARING EN BANC
Lynn H. Pasahow, Fenwick & West LLP, of Palo Alto, CA, filed a response to the petition for rehearing for plaintiffs-appellants. Of counsel on the response were Beth H. Parker, and S. Christian Platt, Bingham McCutchen, LLP, of San Francisco, CA.
Robert E. Hillman, Fish & Richardson, P.C., of Boston, MA, filed a combined petition for panel rehearing and rehearing en banc for defendant-appellee. Of counsel on the petition were Shelley K. Wessels, Karen I. Boyd, and Kurtis D. MacFerrin, Fish & Richardson, P.C., of Redwood City, CA. Also of counsel was Chad A. Hanson, Fish & Richardson, P.C., of Minneapolis, MN.
A combined petition for panel rehearing and rehearing en banc having been filed by the Appellee, a response thereto having been invited by the court and filed by the Appellants, the petition for panel rehearing having been referred to the panel that heard the appeal, thereafter the petition for rehearing en banc and response having been referred to the circuit judges who are in regular active service, and a poll having been requested and taken,
IT IS ORDERED THAT:
(1) The petition for panel rehearing is denied.
(2) The petition for rehearing en banc is granted.
(3) Acting en banc, the court vacates the panel's judgment and original opinion entered August 30, 2002, Elan Pharmaceuticals, Inc. v. Mayo Foundation, 304 F.3d 1221 (Fed.Cir.2002).
To continue reading
Request your trial
-
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., CIvil Action No. 02-11280-RWZ.
...("[I]t must be shown that the undisclosed information was known to be present in the Page 131 subject matter of the reference."), vacated 314 F.3d 1299 (Fed.Cir.2002), and superceded 346 F.3d 1051 (Fed.Cir.2003). However, that decision was, vacated and the new decision does not contain a si......
-
Ex parte Hu, Appeal 2018-003398
...Elan Pharms., Inc. v. Mayo Found., 304 F.3d 1221 (Fed. Cir.), Dyk, J., dissenting (distinguishing inherency from hindsight), vacated at 314 F.3d 1299 (Fed. Cir. 2002) (en banc). [6] See claim l ("such that when said first container is filled with said chemical substance is disposed next to ......
-
Elan Pharmaceuticals v. Mayo Foundation, 00-1467.
...this appeal, reported at Elan Pharmaceuticals, Inc. v. Mayo Foundation, 304 F.3d 1221, 64 USPQ2d 1292 (Fed.Cir.2002), has been vacated, 314 F.3d 1299 (Fed.Cir.2002) (en banc) and is replaced with this opinion and The United States District Court for the Northern District of California, gran......
-
Ex parte Baker, Appeal 2021-002880
...source." Elan Pharmaceuticals, Inc. v. Mayo Foundation, 304 F.3d 1221 (Fed. Cir. 2002) (citation omitted), J. Dyk, dissenting (vacated at 314 F.3d 1299 (Fed. Cir. 2002) (en banc), superseded by 346 F.3d 1051); see also, In re Thorpe, 777 F.2d 695, 697-99 (Fed. Cir. 1985) (admissions in an a......
-
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., CIvil Action No. 02-11280-RWZ.
...("[I]t must be shown that the undisclosed information was known to be present in the Page 131 subject matter of the reference."), vacated 314 F.3d 1299 (Fed.Cir.2002), and superceded 346 F.3d 1051 (Fed.Cir.2003). However, that decision was, vacated and the new decision does not contain a si......
-
Ex parte Hu, Appeal 2018-003398
...Elan Pharms., Inc. v. Mayo Found., 304 F.3d 1221 (Fed. Cir.), Dyk, J., dissenting (distinguishing inherency from hindsight), vacated at 314 F.3d 1299 (Fed. Cir. 2002) (en banc). [6] See claim l ("such that when said first container is filled with said chemical substance is disposed next to ......
-
Elan Pharmaceuticals v. Mayo Foundation, 00-1467.
...this appeal, reported at Elan Pharmaceuticals, Inc. v. Mayo Foundation, 304 F.3d 1221, 64 USPQ2d 1292 (Fed.Cir.2002), has been vacated, 314 F.3d 1299 (Fed.Cir.2002) (en banc) and is replaced with this opinion and The United States District Court for the Northern District of California, gran......
-
Ex parte Baker, Appeal 2021-002880
...source." Elan Pharmaceuticals, Inc. v. Mayo Foundation, 304 F.3d 1221 (Fed. Cir. 2002) (citation omitted), J. Dyk, dissenting (vacated at 314 F.3d 1299 (Fed. Cir. 2002) (en banc), superseded by 346 F.3d 1051); see also, In re Thorpe, 777 F.2d 695, 697-99 (Fed. Cir. 1985) (admissions in an a......